Paysign Reports Strong 2025 Results with 40% Revenue Growth and Margin Expansion
Paysign Segment Surges 167% as Patient Affordability Programs Fuel Growth and Profitability Paysign, Inc. delivered a strong financial performance in 2025, marked by significant revenue growth, improved profitability, and expanding margins, driven largely by its patient affordability business. The company’s…
U.S. FDA Approves Faster Thaw Time Update for ADSTILADRIN Therapy
U.S. FDA Approves Updated Label for ADSTILADRIN to Enable Faster Thawing and Improve Clinical Efficiency Ferring Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has approved a label update for ADSTILADRIN® (nadofaragene firadenovec-vncg), introducing an accelerated water-bath…
Pediatrix Appoints Two Nationally Recognized Physician Leaders
Pediatrix Strengthens Clinical Leadership with Appointment of Two Distinguished Physician Experts Pediatrix® Medical Group,a leading provider of physician services focused on women, babies and children, has announced the addition of two highly respected physician leaders to its executive and clinical…
InterSystems Appoints Dr. Tim Ferris as VP of Healthcare Practices
InterSystems Appoints Dr. Tim Ferris as Vice President of Healthcare Practices InterSystems, a global provider of advanced data technology solutions that supports the management of more than one billion healthcare data transactions worldwide, has announced the appointment of Dr. Tim…
SBC Medical Unveils Next-Generation “SBC Wellness 2.0” Strategy
SBC Medical Launches “SBC Wellness 2.0” to Lead the Future of Performance Medicine and Longevity Care SBC Medical Group Holdings Incorporated (Nasdaq: SBC), a management services organization that partners with a wide network of franchised medical businesses, has announced the…
Affiliated Dermatologists & Dermatologic Surgeons Partners with Epiphany Dermatology
Epiphany Dermatology Expands into New Jersey Through Strategic Partnership with Affiliated Dermatologists & Dermatologic Surgeons Epiphany Dermatology, a prominent and rapidly growing dermatology platform dedicated to enhancing access to high-quality skin care, has announced its entry into the New Jersey…
UL Chemical Insights to Present Safety Research at SOT 65th Annual Meeting & ToxExpo
UL Research Institutes’ Chemical Insights to Present Safety Science Research at Society of Toxicology 65th Annual Meeting and ToxExpo UL Research Institutes’ Chemical Insights is set to play a significant role at the Society of Toxicology’s (SOT) 65th Annual Meeting…
Sesh Products US Nicotine Pouch Bundled PMTA Progresses FDA Substantive Scientific Review Stage
FDA Accepts Application Covering 64 SKUs, Moving Sesh Closer to Potential Marketing Authorization Sesh Products US, Inc. has announced a significant regulatory milestone in its efforts to bring its nicotine pouch products to the U.S. market. The company confirmed that…
Gilead Sciences Expands Autoimmune Pipeline with Acquisition of Ouro Medicines
Gilead Sciences Moves to Acquire Ouro Medicines, Strengthening Its Autoimmune and Inflammation Pipeline with Innovative T-Cell Engager Technology Gilead Sciences has announced a major strategic step to expand its presence in the autoimmune disease space through a definitive agreement to…
Biocytok–Moonlight Bio Partner on Human Antibody Cell Therapy
Biocytok and Moonlight Bio Collaborate to Advance Cell Therapy with Fully Human Antibody Library Biocytogen (Beijing) Pharmaceutical Technology a globally focused biotechnology company known for its innovative platforms in drug discovery and development, has entered into a strategic collaboration agreement…
Bristol Myers Squibb Advances Hodgkin Lymphoma Care Expanded Opdivo Approvals
Bristol Myers Squibb gains U.S. Food and Drug Administration and European Medicines Agency approvals, expanding Opdivo use in Hodgkin lymphoma Bristol Myers Squibb has announced significant regulatory milestones that mark a major advancement in the treatment landscape for classical Hodgkin…
Incyte Highlights Late-Breaking HS Data at AAD 2026
Incyte Showcases HS Data at AAD 2026 Incyte has announced that it will present a comprehensive set of new clinical data from its Inflammation and Autoimmunity (IAI) portfolio at the American Academy of Dermatology Annual Meeting 2026, scheduled to take…